Reports world wide Multiple Sclerosis Forecast | 页面 2

Figure 5: Multiple sclerosis market sales across the US, Japan, and five major EU markets, by disease subtype, 2016–25 Figure 6: Methodology flow for Datamonitor Healthcare’s multiple sclerosis forecast Figure 7: Price sources and calculations, by country Figure 8: ALKS 8700 for multiple sclerosis – SWOT analysis CONTINUED…………………………… LIST OF TABLES Table 1: Multiple sclerosis market sales across the US, Japan, and five major EU markets, by country ($m), 2016–25 Table 2: Multiple sclerosis market sales across the US, Japan, and five major EU markets, by formulation ($m), 2016–25 Table 3: Multiple sclerosis market sales across the US, Japan, and five major EU markets, by disease subtype ($m), 2016–25 Table 4: Multiple sclerosis market treated patient numbers across the US, Japan, and five major EU markets, by disease subtype, 2016–25 Table 5: Sales of the top three highest selling drugs in multiple sclerosis in 2025 across the US, Japan, and five major EU markets ($m), 2016–25 Table 6: Summary of drug classes and molecules included in Datamonitor Healthcare’s multiple sclerosis patient-based forecast Table 7: Exchange rates used for calculating prices Table 8: Neurologists surveyed for the multiple sclerosis primary research study, 2016 Table 9: ALKS 8700 drug profile Table 10: ALKS 8700 Phase III trials in multiple sclerosis CONTINUED…………………………… Ask to Expertise @ https://www.reportsworldwide.com/enquiry?report_id=42618 About US: Reportsworldwide.com is a one stop shop for all market intelligence needs. Our database of market research reports provides in depth coverage of 12 top industry verticals worldwide. We help you meet your market intelligence needs by mapping it with our database of market research reports including. Contact Us: Email: [email protected] Phone: [phone]